Esperion to Participate in Upcoming Virtual Investor Conference
October 27 2021 - 4:01PM
Esperion (NASDAQ: ESPR) today announced that members of Esperion’s
management team will participate in the upcoming Credit Suisse 30th
Annual Healthcare Conference.
Event: |
Credit Suisse
30th Annual Healthcare Conference |
Date: |
Tuesday, November 9, 2021 |
Format: |
Fireside Chat and 1:1 Meetings |
Time: |
4:20 p.m. ET |
Live audio webcasts of these events can be accessed on the
investor relations section of the Esperion website at
www.esperion.com/investors-media/events-presentations/. Replays of
the webcasts will be archived on the Company's website for 90 days
following the events.
Esperion Therapeutics
Esperion is The Lipid Management Company. Our goal is lipid
management for everybody, that’s why we work hard to make our
medicines easy to get, easy to take and easy to have. We discover,
develop and commercialize innovative medicines and combinations to
lower cholesterol, especially for patients whose needs aren’t being
met by the status quo. Our entrepreneurial team of industry leaders
is inclusive, passionate and resourceful. For more information,
please visit www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Investor Contact:Kaitlyn
BroscoEsperioncorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Sep 2023 to Sep 2024